In stock
Tesamorelin
GH Axis
GH Axis
£49.99
Free 24-hour delivery over £75 · Same-day dispatchOrder before 2pm - same-day dispatch · Free 24-hour delivery over £75
Tissue Repair
BPC-157
- Purity
- >= 99% (HPLC)
- Form
- Lyophilised powder
- Origin
- United States
Manufactured for laboratory research. Not for human or veterinary use. Read full disclaimer →
BPC-157 is a synthetic 15-amino-acid peptide (pentadecapeptide) studied in research into tissue-repair, angiogenic and cell-signalling pathways in experimental models.
- Purity >= 99% (HPLC)
- Supplied as a lyophilised powder
- Independent batch identity and purity testing
- For laboratory research use only; not for human or veterinary use
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide: a chain of 15 amino acids corresponding to a partial sequence of a protein identified in gastric juice, which is why the literature files it as the "stable gastric pentadecapeptide". It carries no cysteine and no disulfide bond, and is supplied here as a lyophilised research reagent for in-vitro and laboratory use only. The name is earned: where most peptides dissolve on contact with stomach acid, this one is reported stable in it. Not for human or veterinary use.
Is BPC-157 legal in the UK?
BPC-157 is not currently a controlled drug in the UK. It is supplied here strictly as a research chemical for laboratory use only, and because it is not licensed as a medicine it cannot lawfully be sold or supplied for human consumption. Purchasers confirm they are acquiring it for legitimate research and are responsible for compliance with their own institutional policies and applicable law. See the full research disclaimer for the complete position.
How is the identity and quality of this material assured?
A vial labelled BPC-157 is not the same as a vial confirmed as BPC-157, so identity and purity should be verifiable rather than assumed. Every Kovalabs batch is released only after independent identity and purity testing (99%+ by HPLC) and ships with a Certificate of Analysis, so the mass and purity in hand can be checked against the documented identifiers (formula C62H98N16O22, CAS 137525-51-0, PubChem CID 9941957) rather than taken on trust. The full chemical data sheet, including SMILES, InChIKey and the molecular structure, is in the Specifications tab; per-batch certificates are in the Testing reports.
What does the research on BPC-157 investigate?
The published BPC-157 literature is overwhelmingly in-vitro and animal-model, examined in cultured cells and rodents, and the human evidence is essentially absent. These are research directions, not conclusions: the studies describe what was measured in non-clinical systems, and none of them establishes an outcome in humans. Nothing here describes a use, benefit, dose or effect in people. For the full research picture, the verified citations, and an honest tier-by-tier assessment of how strong the evidence actually is, see the BPC-157 research monograph.
Synthesis and supply
Manufactured by controlled solid-phase peptide synthesis and finished as a white-to-off-white lyophilised solid, with each batch released after independent testing. Researchers working across the tissue-repair set often pair it with TB-500; both sit in the tissue-repair research category.
External resources for researchers
- 2D structure
- Product name
- BPC-157 (Body Protection Compound)
- Synonyms
- Pentadecapeptide BPC-157, PL 14736, Bepecin
- Sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Molecular formula
- C62H98N16O22
- Molecular weight
- 1419.5 g/mol
- InChIKey
- HEEWEZGQMLZMFE-RKGINYAYSA-N
- CAS number
- 137525-51-0
- PubChem CID
- 9941957
- Purity
- >= 99% (HPLC)
- Form
- Lyophilised powder
- Appearance
- White to off-white solid
- Solubility
- Bacteriostatic water
- Storage
- Lyophilised: store at -20C, dry and light-protected. Reconstituted: 2-8C.
- What is BPC-157?
- BPC-157 is a synthetic pentadecapeptide: a chain of 15 amino acids corresponding to a partial sequence of a protein identified in gastric juice, which is why the literature files it as the 'stable gastric pentadecapeptide'. It carries no cysteine and no disulfide bond. It is supplied here strictly as a lyophilised research reagent for in-vitro and laboratory use, not as a medicine.
- What does the research on BPC-157 investigate?
- Published BPC-157 work is overwhelmingly in-vitro and animal-model, and is studied for its possible role in tissue-remodelling and nitric-oxide-system and angiogenic signalling, examined in cultured cells and rodents. These are research directions, not conclusions: the studies describe what was measured in non-clinical systems, and none of them establishes an outcome in humans. Nothing here describes a use, benefit, dose or effect in people.
- Has BPC-157 been shown to be safe or effective in humans?
- No. BPC-157 has not been evaluated by the MHRA or any comparable regulator, and rigorous controlled human data is essentially absent despite an old pharmaceutical development code (PL-14736). It is not a licensed medicine and is supplied strictly for laboratory research, not for human or veterinary use. Questions of human safety or efficacy are therefore unanswered, and no such claim is made.
- Is BPC-157 legal in the UK?
- BPC-157 is not a controlled drug in the UK, and it is supplied here strictly as a research chemical for laboratory use only, not for human or veterinary use. It is not licensed as a medicine, so it cannot lawfully be sold or supplied for human consumption. Purchasers confirm they are acquiring it for legitimate research and are responsible for compliance with their own institutional policies and applicable law.
- Are all BPC-157 products the same?
- Not necessarily, which is exactly why a Certificate of Analysis earns its keep: a vial labelled BPC-157 is not the same as a vial confirmed as BPC-157. Every Kovalabs batch ships with a CoA so the mass and purity in hand can be checked against the documented identifiers (formula C62H98N16O22, CAS 137525-51-0, PubChem CID 9941957) instead of taken on trust.
- What are the molecular formula and weight of BPC-157?
- The molecular formula is C62H98N16O22 and the average molecular weight is 1419.5 g/mol (free base). It is indexed under PubChem CID 9941957 and CAS 137525-51-0, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Salt forms (for example acetate) carry a different mass, so confirm the form against the lot Certificate of Analysis.
- How is BPC-157 supplied and reconstituted?
- It is supplied as a white-to-off-white lyophilised solid in a sealed vial. As a hydrophilic, cysteine-free peptide it dissolves readily in an appropriate aqueous laboratory solvent; bacteriostatic water is a common choice for research reconstitution. This is bench reconstitution of a reagent for analysis, following your own laboratory SOPs, and is not a preparation method for any use in humans or animals. See the Reconstitution and storage tab for the standard workflow.
- How should BPC-157 be stored?
- Store the sealed lyophilised powder at -20C, kept dry and protected from light; equilibrate to room temperature before opening to limit condensation. Reconstituted solution is held at 2-8C and used within your validated stability window, with freeze-thaw cycles minimised. See the Reconstitution and storage tab for the standard bench workflow.
- Is BPC-157 banned in sport / on the WADA list?
- Yes. BPC-157 is included on the WADA Prohibited List under category S0 (non-approved substances), prohibited at all times, and has been since 2022. This is stated only as regulatory and analytical context for researchers; it is not a comment on, or endorsement of, any use in humans or in sport.
- Is a Certificate of Analysis available?
- Yes. Every batch is independently identity- and purity-tested (99%+ by HPLC) and a Certificate of Analysis is available. See the Testing reports tab on this page, or the certificates of analysis library.
- Is BPC-157 intended for human use?
- No. BPC-157 supplied here is strictly for in-vitro laboratory research. It is not a medicine, food, supplement or cosmetic, is not for human or veterinary use, and nothing on this page is a medicinal, therapeutic, healing, efficacy or dosing claim.
| Date | Batch no | Issuing lab | Lab report | View QR |
|---|---|---|---|---|
| 09 Feb 2026 | BPC-2026-01 | Janoshik | View report |
Calculator
Research planning only
Concentration2.50 mg/ml
Volume to draw0.100 ml
Insulin syringe (100 IU/ml)
10.0units
For research planning only. Not medical, dosing, or therapeutic advice. All Kovalabs products are research-use-only.
Store unreconstituted vials at −20°C for long-term, or refrigerated at 2-8°C for short-term use. Avoid repeated freeze-thaw cycles.
Reconstitute with bacteriostatic water down the inside wall of the vial; gently swirl to dissolve. Do not shake.
Once reconstituted, refrigerate at 2-8°C and use within 2-4 weeks. Discard if cloudy, discoloured, or particulate.
